Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | HRH4 | Q9H3N8 | 2/20 | 0.34 |
| ▸ | HRH2 | P25021 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | MAOA | P21397 | 1/20 | 0.32 |
| ▸ | MAOB | P27338 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28506360 | 0.98 | CYP1A2 (0.47) | CYP1A2CYP2D6ALDH1A1TSHRDNM1 | |
| SCHEMBL992203 | 0.98 | ALDH1A1 (0.50) | CYP1A2CYP2D6ALDH1A1TSHRDNM1 | |
| Hydrochloric Acid SCHEMBL839371 | 0.96 | ALDH1A1 (0.48) | CYP1A2CYP2D6ALDH1A1TSHRDNM1 | |
| SCHEMBL301678 | 0.93 | — | — | |
| Ethane SCHEMBL8026831 | 0.91 | CYP1A2 (0.54) | CYP1A2CYP2D6ALDH1A1TSHRDNM1 | |
| Hydrochloric Acid SCHEMBL248532 | 0.91 | CYP1A2 (0.54) | CYP1A2CYP2D6ALDH1A1TSHRDNM1 | |
| Carbimide SCHEMBL8927383 | 0.91 | CYP1A2 (0.54) | CYP1A2CYP2D6ALDH1A1TSHRDNM1 | |
| Ethane SCHEMBL2545448 | 0.88 | CYP1A2 (0.52) | CYP1A2CYP2D6ALDH1A1TSHRDNM1 | |
| Iodomethane SCHEMBL7521844 | 0.88 | CYP1A2 (0.52) | CYP1A2CYP2D6ALDH1A1TSHRDNM1 | |
| Hydrochloric Acid SCHEMBL28296907 | 0.88 | CYP1A2 (0.52) | CYP1A2CYP2D6ALDH1A1TSHRDNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104428331-B | Active energy beam polymer resin composition and the laminated body for using the resin combination | 东洋油墨SC控股株式会社 | 2019-02-15 | — | — | CN | disclosed |
| CN-104428331-A | Active energy ray-polymerizable resin composition and laminate obtained using resin composition | TOYO INK SC HOLDINGS CO LTD | 2015-03-18 | — | — | CN | disclosed |
| US-8357717-B2 | Spiro group-containing amide compounds having bradykinin 1 receptor (B1R) activity | GRUENENTHAL GMBH (DE) | 2013-01-22 | — | — | US | disclosed |
| US-20100234340-A1 | Substituted Spiroamide Compounds | GRUENENTHAL GMBH (DE) | 2010-09-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100234340-A1 | Substituted Spiroamide Compounds | BDKRB1, BDKRB2, AVPR1B | CYP1A2 1392/4885CYP2D6 950/4885ALDH1A1 1303/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.